戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1                                         Both cholangiographic and hepatic histologic findings suggest
2 of recurrent PSC was based on characteristic cholangiographic and histologic findings that occur in n
3  group A, recurrent disease, as evidenced by cholangiographic and pathologic findings with radiograph
4 gs (clinical, biochemical, histological, and cholangiographic) and side effects of a 2-year double-bl
5                                 Based on the cholangiographic appearance and clinical situation, pati
6 chemical abnormalities but not in histology, cholangiographic appearance or survival.
7                              On the basis of cholangiographic appearance, BDFDs were categorized as s
8 nd a significant reduction in progression in cholangiographic appearances (P = 0.015) and liver fibro
9 uccess of endoscopic treatment and suggest a cholangiographic classification.
10 t diagnostic of PSC, the diagnosis requiring cholangiographic demonstration of stricturing and dilata
11                                   Subsequent cholangiographic examinations in these patients increase
12                      The most common type of cholangiographic feature of intrahepatic duct involvemen
13 hnique remain investigation of indeterminate cholangiographic findings and management of large bile d
14  and clinical data were recorded, along with cholangiographic findings and the frequency of large duc
15 iagnosed to have PSC on the basis of typical cholangiographic findings in combination with clinical a
16                                           MR cholangiographic findings were correlated with findings
17 ging findings, independently reviewed the MR cholangiographic images to assess the presence of biliar
18 t donor candidates were examined with two MR cholangiographic methods.
19 phy require further study in comparison with cholangiographic techniques.